Spectral flow cytometry in practice: how full spectrum detection and unmixing differ from compensation, what autofluorescence extraction actually buys, and the single stained controls a spectral panel cannot be run without
A spectral cytometer measures the whole emission signature of every event across many detectors and then solves for which fluorophores produced it. That changes what panels are possible and changes how they fail. The failures are quieter than compensation errors and easier to publish by accident. This page covers what the approach does and how to run it honestly.
- the containment unfixed human samples are handled at
- BSL-2
- single stained reference controls a spectral panel requires
- 1 per dye
- the competence standard an accredited cytometry service holds
- ISO 17025
Figures in this panel are the control requirement the method imposes and the biosafety and competence standards the work is done under, linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and does not imply an instrument price index it has not measured.
- 4 vendor service pages verifiedevery figure matched verbatim to the vendor's page
- Quoted and dated, never estimatedlast verification pass 2026-08-24
- 1 service classes coveredeach with measured search demand behind it
Running a spectral panel
- Understand what unmixing is solving. Conventional cytometry assigns one detector to each fluorophore and corrects for spillover. A spectral instrument records the full emission signature and solves a system of equations for the contribution of each fluorophore. It can separate dyes with similar peaks but different shapes, which filter-based detection cannot.
- Record a reference signature for every fluorophore, on the right carrier. Unmixing needs a pure signature per fluorophore, from a single stained control. The carrier matters: beads and cells give different signatures for the same dye, and mixing carriers between controls is the commonest cause of unmixing artefacts.
- Take autofluorescence seriously, because you now can. An unstained control from the same sample type lets autofluorescence be treated as an additional signature and extracted. On tissue, macrophages and anything fixed, that is a substantial gain, and it requires an unstained control per sample type rather than one for the run.
- Check the unmixing before gating anything. Look at the unmixed data for populations that have moved off-axis or acquired an impossible shape. Spectral unmixing errors look like biology, which is why the check is visual and deliberate rather than automatic.
- Design the panel by similarity, not by peak. Two dyes with the same peak and different shapes can be resolved; two with very similar full spectra cannot, whatever their peaks. Use a similarity measure rather than a colour chart, and put the most similar pair on the most distinct antigens.
Titration still decides the panel's quality
Every conjugate has to be titrated on the sample type it will be used on. Over-concentrated reagents raise spread into every other channel, and on a large panel that cost is paid by the markers you care most about.
Titrate in the final buffer and with the final protocol, including fixation. A reagent titrated on fresh cells and used on fixed ones is not titrated.
Sample preparation and viability
Dead cells bind antibody non-specifically and fluoresce broadly, which is exactly what unmixing cannot tolerate. A viability dye is not optional on a spectral panel and should be included even where the sample is expected to be clean.
Filter samples before acquisition. A clog partway through a run changes the signal and invalidates the portion after it, and on long acquisitions that can be most of the sample.
Data volume and analysis
Spectral files are large and the raw detector data is worth keeping, because unmixing can be redone with better references and gating cannot be undone once the raw data is discarded. Plan storage before the first big study rather than during it.
Record the reference set used for each unmixing with the data. Two analyses of one experiment with different reference controls will disagree, and without the record nobody can tell which is which.
Common questions
- How is spectral flow cytometry different from conventional cytometry?
- It measures each event's whole emission spectrum across many detectors and solves for fluorophore contributions, rather than assigning one filtered detector per dye and compensating spillover. That allows larger panels and dyes with overlapping peaks.
- Do I still need single stained controls?
- More than before. Unmixing is only as good as the reference signature of each fluorophore, so every dye in the panel needs a single stained control on a carrier that matches the experiment.
- What does autofluorescence extraction do?
- It treats the sample's own fluorescence as another signature to be solved out, using an unstained control from that sample type. On tissue and fixed samples it can recover dim populations that would otherwise be buried.
- Does spectral cytometry remove the need for careful panel design?
- No. It changes the constraint from filter availability to spectral similarity. Two dyes with nearly identical full spectra remain inseparable, and spread still costs resolution on the dimmest markers.
Get a shortlist for your project
Browse by service class
Sources
Cite or embed this figure
The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.
Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/spectral-flow-cytometry/.